Mersana Therapeutics, Inc. ($MRSN)
Filing Information
| Accession Number | 0001104659-26-001385 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 6, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
9,759
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 6, 2026 | Unknown | 578 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 6, 2026 | Sale to Issuer | 2,460 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 6, 2026 | Sale to Issuer | 1,571 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 6, 2026 | Sale to Issuer | 416 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 6, 2026 | Sale to Issuer | 1,800 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 6, 2026 | Sale to Issuer | 734 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 6, 2026 | Sale to Issuer | 2,200 | โ | โ | 0 | Direct | โ | View Details |